methylselenic acid has been researched along with nu 7026 in 1 studies
| Studies (methylselenic acid) | Trials (methylselenic acid) | Recent Studies (post-2010) (methylselenic acid) | Studies (nu 7026) | Trials (nu 7026) | Recent Studies (post-2010) (nu 7026) |
|---|---|---|---|---|---|
| 144 | 1 | 68 | 70 | 0 | 44 |
| Protein | Taxonomy | methylselenic acid (IC50) | nu 7026 (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 6.4 | |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | 0.2388 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, L; Cheng, WH; Fu, Y; Tzeng, TJ; Zeng, H | 1 |
1 other study(ies) available for methylselenic acid and nu 7026
| Article | Year |
|---|---|
Methylseleninic acid sensitizes Notch3-activated OVCA429 ovarian cancer cells to carboplatin.
Topics: Acetylcysteine; Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Carboplatin; Cell Cycle; Cell Line, Tumor; Chromones; DNA-Binding Proteins; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Morpholines; Organoselenium Compounds; Ovarian Neoplasms; Phosphorylation; Receptor, Notch3; Receptors, Notch; RNA, Messenger; Thioxanthenes | 2014 |